Fluxergy has expanded it’s U.S. headquarters after commercializing the test globally. The expansion will enable the company to ramp up production of the rapid test as well as further develop the test platform for other uses.
Join Tej Patel, the President and co-founder of Fluxergy, as he talks about the current state of medical diagnostic testing, the inspiration for starting the company, and what the future of Fluxergy looks like.
Being able to cost-effectively detect agents of concern like listeria, campylobacter, and salmonella within 30 minutes of sample collection allows for real-time monitoring of the product throughout its lifecycle to prevent a recall of inventory and ill effects to consumers.
President Tej Patel shares his insights on education and specific advice for landing a job in the life sciences during the pandemic. His team includes backgrounds in the semiconductor, aerospace, and automotive industries.
Fluxergy is looking for partners to help bring its CE-marked COVID-19 test to market. The automated testing platform has multimodal capability allowing for a variety of assay types to be run simultaneously on the same cartridge.
Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry
IRVINE, CA., March 25, 2021 – Fluxergy, Inc., a medical diagnostic testing platform company with a detection technology solution capable of multimodality, announced today that it has obtained CE marking for its one-hour COVID-19 RT-PCR test, to use by healthcare professionals as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2. The CE-mark will allow […]